Article
Evaluation of potential of targeted sequencing through mutational signature simulation.
PloS one - 1 Jan 2025
Kodama Keisuke, Ling Yiwei, Ichikawa Hiroshi, Wakai Toshifumi, Okuda Shujiro
Abstract excerpt
BACKGROUND: Targeted sequencing is critical in cancer diagnosis, treatment selection, and monitoring. However, the effectiveness of these methods for reflecting whole-exome sequencing (WES)-level mutational signatures remains unclear. Therefore, we addressed this issue through simulation-based analysis to clarify how well targeted sequencing can reproduce WES-level mutational signatures. METHODS: We compared the...
Read the complete abstract on PubMedTopics
- Humans
- Mutation
- Neoplasms
- Exome Sequencing
- Computer Simulation
- Exome
- High-Throughput Nucleotide Sequencing
